Biodistribution and gene expression of lipid/plasmid complexes after systemic administration

Area of Science:

• Biotechnology
• Gene Therapy
• Materials Science

Background:

• Lipid/plasmid complexes are crucial for in vivo gene delivery.
• Understanding the impact of physicochemical properties is key to optimizing gene transfer.
• Biodegradable cationic lipids offer potential advantages over traditional formulations.

Purpose of the Study:

• To investigate how physicochemical properties of lipid/plasmid complexes affect gene transfer and biodistribution.
• To assess the gene expression efficacy of novel biodegradable cationic lipids.
• To identify optimal formulation parameters for enhanced in vivo gene delivery.

Main Methods:

• Formulations using DOTMA and novel biodegradable cationic lipids (EDOPC, EPMPC, MMCE, DOLCE) were prepared.
• Lipid/plasmid complexes were administered intravenously to mice via tail vein injection.
• Gene expression (hGH, hFIX, CAT) and plasmid DNA biodistribution were quantified.
• Effects of varying cationic lipid structure, ratios, charge, and liposome size were analyzed.

Main Results:

• Gene expression was significantly influenced by cationic lipid structure, lipid:colipid ratios, charge ratios, and liposome size.
• Positively charged complexes (400-nm liposomes, 4:1 cationic lipid:colipid ratio) yielded detectable hGH, hFIX, and CAT expression.
• Plasmid DNA primarily distributed to the lung at 15 min, with increasing liver accumulation over 24 hr.
• The biodegradable lipid DOLCE demonstrated high efficacy, and specific charge ratios (3:1) were optimal for gene expression.

Conclusions:

• Physicochemical properties of lipid/plasmid complexes critically determine in vivo gene transfer and biodistribution.
• Biodegradable cationic lipids, particularly DOLCE, represent a promising platform for gene therapy.
• Optimizing cationic lipid structure, charge ratios, and formulation parameters is essential for efficient and targeted gene delivery.